245 related articles for article (PubMed ID: 28790404)
1. Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations.
Couñago RM; Allerston CK; Savitsky P; Azevedo H; Godoi PH; Wells CI; Mascarello A; de Souza Gama FH; Massirer KB; Zuercher WJ; Guimarães CRW; Gileadi O
Sci Rep; 2017 Aug; 7(1):7501. PubMed ID: 28790404
[TBL] [Abstract][Full Text] [Related]
2. Role of bivalent cations in structural stabilities of new drug targets--vaccinia-related kinases (VRK) from molecular dynamics simulations.
Fu T; Ren H; Zhang J; Ren P; Enyedy I; Li G
Curr Pharm Des; 2013; 19(12):2269-81. PubMed ID: 23082977
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibitor sensitivity between human kinases VRK1 and VRK2.
Vázquez-Cedeira M; Barcia-Sanjurjo I; Sanz-García M; Barcia R; Lazo PA
PLoS One; 2011; 6(8):e23235. PubMed ID: 21829721
[TBL] [Abstract][Full Text] [Related]
4. Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities.
Sanz-García M; López-Sánchez I; Lazo PA
Mol Cell Proteomics; 2008 Nov; 7(11):2199-214. PubMed ID: 18617507
[TBL] [Abstract][Full Text] [Related]
5. NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin.
Melo-Hanchuk TD; Slepicka PF; Meirelles GV; Basei FL; Lovato DV; Granato DC; Pauletti BA; Domingues RR; Leme AFP; Pelegrini AL; Lenz G; Knapp S; Elkins JM; Kobarg J
Sci Rep; 2017 Jul; 7(1):5445. PubMed ID: 28710492
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for MARK1 Kinase Autoinhibition by Its KA1 Domain.
Emptage RP; Lemmon MA; Ferguson KM; Marmorstein R
Structure; 2018 Aug; 26(8):1137-1143.e3. PubMed ID: 30099988
[TBL] [Abstract][Full Text] [Related]
7. Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313.
Talapati SR; Nataraj V; Pothuganti M; Gore S; Ramachandra M; Antony T; More SS; Krishnamurthy NR
Acta Crystallogr F Struct Biol Commun; 2020 Aug; 76(Pt 8):350-356. PubMed ID: 32744246
[TBL] [Abstract][Full Text] [Related]
8. The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.
Rico AB; Linville AC; Olson AT; Wang Z; Wiebe MS
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177193
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.
Hiruma Y; Koch A; Dharadhar S; Joosten RP; Perrakis A
Proteins; 2016 Dec; 84(12):1761-1766. PubMed ID: 27699881
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.
Olson AT; Rico AB; Wang Z; Delhon G; Wiebe MS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515294
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for Auto-Inhibition of the NDR1 Kinase Domain by an Atypically Long Activation Segment.
Xiong S; Lorenzen K; Couzens AL; Templeton CM; Rajendran D; Mao DYL; Juang YC; Chiovitti D; Kurinov I; Guettler S; Gingras AC; Sicheri F
Structure; 2018 Aug; 26(8):1101-1115.e6. PubMed ID: 29983373
[TBL] [Abstract][Full Text] [Related]
13. STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1.
Durzynska I; Xu X; Adelmant G; Ficarro SB; Marto JA; Sliz P; Uljon S; Blacklow SC
Structure; 2017 Feb; 25(2):287-294. PubMed ID: 28089446
[TBL] [Abstract][Full Text] [Related]
14. Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications.
Sanz-García M; Vázquez-Cedeira M; Kellerman E; Renbaum P; Levy-Lahad E; Lazo PA
J Proteomics; 2011 Dec; 75(2):548-60. PubMed ID: 21920476
[TBL] [Abstract][Full Text] [Related]
15. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase.
Nezu J; Oku A; Jones MH; Shimane M
Genomics; 1997 Oct; 45(2):327-31. PubMed ID: 9344656
[TBL] [Abstract][Full Text] [Related]
16. Experimentally based structural model of Yih1 provides insight into its function in controlling the key translational regulator Gcn2.
Harjes E; Jameson GB; Tu YH; Burr N; Loo TS; Goroncy AK; Edwards PJB; Harjes S; Munro B; Göbl C; Sattlegger E; Norris GE
FEBS Lett; 2021 Feb; 595(3):324-340. PubMed ID: 33156522
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog.
Ngow YS; Rajan S; Ye H; Yoon HS
Protein Sci; 2019 Mar; 28(3):524-532. PubMed ID: 30461091
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide Binding, Evolutionary Insights, and Interaction Partners of the Pseudokinase Unc-51-like Kinase 4.
Preuss F; Chatterjee D; Mathea S; Shrestha S; St-Germain J; Saha M; Kannan N; Raught B; Rottapel R; Knapp S
Structure; 2020 Nov; 28(11):1184-1196.e6. PubMed ID: 32814032
[TBL] [Abstract][Full Text] [Related]
20. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.
Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
